Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012
Research

Diphtheria in the Postepidemic Period, Europe, 2000–2009

Karen S. WagnerComments to Author , Joanne M. White, Irina Lucenko, David Mercer, Natasha S. Crowcroft, Shona Neal, Androulla Efstratiou, on behalf of the Diphtheria Surveillance Network
Author affiliations: Health Protection Agency, London, UK (K.S. Wagner, J.M. White, N.S. Crowcroft, S. Neal, A. Efstratiou); State Agency Infectology Center of Latvia, Riga, Latvia (I. Lucenko); World Health Organization Regional Office for Europe, Copenhagen, Denmark (D. Mercer); Public Health Ontario, Toronto, Ontario, Canada (N.S. Crowcroft); University of Toronto Dalla Lana School of Public Health, Toronto (N.S. Crowcroft)

Main Article

Table 2

Isolates of toxigenic Corynebacterium ulcerans and patient deaths reported by DIPNET member countries, Europe, 2000–2009*

Characteristic Patient description† No. toxigenic isolates (no. deaths)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Country
France Total 0 1 0 1 3 0 2 1 0 1
Germany Total 1 1 (1) 0 0 1 2 1 2 0 2
Italy Total 0 0 1 0 0 0 0 0 0 0
The Netherlands Total 0 1 0 0 0 0 0 1 0 0
Romania Asymptomatic 0 0 1 0 0 0 0 0 0 0
Total 0 0 1 0 0 0 0 0 0 0
Sweden Symptomatic 0 0 0 0 0 0 0 0 1 0
Not known 0 0 0 0 1 0 1 0 0 0
Total 0 0 0 0 1 0 1 0 1 0
United Kingdom Total 7 (1) 3 2 2 1 2 2 (1) 3 3 2
No. symptomatic patients NA 8 6 3 3 5 4 5 7 4 5
No. isolates NA 8 (1) 6 (1) 4 3 6 4 6 (1) 7 4 5

*DIPNET, Diphtheria Surveillance Network; NA, not applicable
†If only total is shown for a country, all patients were symptomatic.

Main Article

1Additional members of the Diphtheria Surveillance Network who contributed data are listed in Technical Appendix 1.

Page created: January 17, 2012
Page updated: January 17, 2012
Page reviewed: January 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external